SLC23A1 Gene: Vitamin C Transporter Genetics and Why Some People Need More
Humans cannot synthesize vitamin C — we lost the GULO gene approximately 61 million years ago. Every molecule of ascorbate in your body entered through the diet and was transported across your intestinal wall by SVCT1, the sodium-dependent vitamin C transporter encoded by SLC23A1. Variants that reduce this transporter's efficiency create a dose-response gap: the same vitamin C intake produces lower plasma levels in affected individuals, raising their functional requirement for both dietary sources and supplementation.
Key Variant
SLC23A1 S279F (Ser279Phe)
T allele (Phe279) reduces SVCT1 transporter function. Carriers show lower plasma vitamin C concentrations at equivalent intake. Relatively rare variant (~2-5% allele frequency in Europeans) but included in 23andMe data. Associated with higher dietary vitamin C requirements and risk of subclinical ascorbate insufficiency in populations with modest vitamin C intake.
SLC23A1 common variant (GWAS-identified)
A GWAS-identified SLC23A1 variant associated with lower vitamin C levels in population studies. Part of a broader haplotype affecting SVCT1 expression levels — more common than rs33972313 and contributes to population-level variation in vitamin C status.
The Vitamin C Transport System
Vitamin C (ascorbic acid) is water-soluble and cannot passively diffuse across intestinal epithelial cell membranes. Its absorption is entirely transporter-dependent, mediated by two sodium-dependent vitamin C transporters:
- SVCT1 (SLC23A1): Expressed in intestinal epithelial cells (enterocytes), kidney tubular cells, and liver. Primary function: absorb vitamin C from dietary sources in the gut and reabsorb it in the kidney to prevent loss in urine. SVCT1 has high capacity but moderate affinity — it handles the bulk absorption of dietary vitamin C.
- SVCT2 (SLC23A2): Expressed in neurons, adrenal glands, eyes, and other tissues with high vitamin C requirements. Low capacity but very high affinity — it concentrates vitamin C in specialized tissues against steep concentration gradients. SVCT2 defects cause embryonic lethality in mice.
The kinetics of SVCT1 matter practically: vitamin C absorption is saturable. At low intakes (50-100mg/day), absorption efficiency is approximately 70-90%. At higher intakes (500mg+), absorption falls to 30-50% and the unabsorbed fraction passes to the colon (explaining the osmotic diarrhea of very high-dose vitamin C). SLC23A1 variants shift this absorption curve downward — the same amount absorbed at any given dose, but the absolute amount absorbed is less.
Population Genetics of Vitamin C Status
A landmark GWAS study by Timpson et al. (2010) in American Journal of Clinical Nutrition examined the genetic determinants of plasma vitamin C levels across approximately 15,000 European individuals. SLC23A1 and SLC23A2 variants together explained a significant fraction of the genetic variance in plasma ascorbate — considerably more than dietary intake alone, and in some cases more than whether participants supplemented.
This finding has important implications: even with identical dietary vitamin C intake, individuals with SVCT1 loss-of-function variants have meaningfully lower plasma ascorbate concentrations. The "recommended dietary allowance" (RDA) of 75-90mg/day was established for average absorbers. It is functionally insufficient for reduced-SVCT1 individuals.
The practical consequence: two people eating identical diets can have very different functional vitamin C status. Standard dietary recommendations ignore the genetic variation in absorption efficiency — creating a class of people who appear to eat adequate vitamin C but remain in the insufficiency range.
What Vitamin C Actually Does (Beyond Scurvy Prevention)
The classical vitamin C deficiency disease, scurvy, results from inadequate collagen hydroxylation — but this represents severe deficiency. Subclinical insufficiency produces more subtle but clinically significant effects:
- Collagen synthesis: Vitamin C is a cofactor for prolyl and lysyl hydroxylases — enzymes that hydroxylate proline and lysine residues in procollagen, enabling proper collagen cross-linking. Suboptimal vitamin C impairs collagen quality before frank deficiency causes scurvy.
- Norepinephrine synthesis: Dopamine-beta-hydroxylase, the enzyme that converts dopamine to norepinephrine, requires vitamin C as a cofactor. Low vitamin C can reduce norepinephrine synthesis — the adrenal glands have extremely high SVCT2 expression because of this dependence.
- Iron absorption: Vitamin C reduces ferric (Fe3+) to ferrous (Fe2+) iron in the intestinal lumen, dramatically increasing non-heme iron absorption. For vegetarians and vegans who rely on non-heme plant iron, vitamin C with each iron-containing meal can double or triple iron bioavailability.
- Antioxidant activity: Vitamin C is the primary water-soluble antioxidant in plasma and intracellular fluid. It scavenges reactive oxygen species, regenerates vitamin E from its oxidized form, and maintains glutathione in its reduced state.
- Immune function: Neutrophils accumulate vitamin C to concentrations 80-fold higher than plasma levels. During infection, vitamin C in neutrophils is rapidly oxidized and discharged. Vitamin C is required for optimal neutrophil chemotaxis, phagocytosis, and killing of pathogens.
- Epigenetic regulation: Vitamin C is a cofactor for TET enzymes that demethylate DNA and histone demethylases — directly regulating gene expression and embryonic stem cell maintenance. This recently-discovered role has implications for cancer prevention and aging.
Dose-Response and Saturation Strategy
For SLC23A1 reduced-function carriers, the absorption curve is shifted — meaning the dose required to achieve saturating plasma levels is higher. The Linus Pauling Institute's optimal vitamin C protocol recommends 400mg/day as the minimum to maintain near-saturating plasma ascorbate (~80 µmol/L) in healthy adults. For SVCT1-impaired individuals, this threshold dose is higher.
Practically: taking multiple smaller doses throughout the day absorbs more than a single large dose, because smaller doses stay below the saturation point of the transporter more effectively. Splitting 500-1,000mg daily vitamin C into 2-3 doses increases total absorbed amount compared to taking it all at once.
Liposomal vitamin C encapsulates ascorbate in phospholipid liposomes that are absorbed partially through a different mechanism (lipid endocytosis) than SVCT1. For individuals with impaired SVCT1 function, liposomal forms may achieve higher plasma levels than equivalent doses of standard ascorbic acid by partially bypassing the transporter deficit.
Protocol for SLC23A1 Reduced-Function Carriers
- Vitamin C 500-1,000mg/day in divided doses: Split into 2-3 doses (morning, afternoon, evening) to stay below the transporter saturation point at each dose. This increases total daily absorption compared to single-dose supplementation. Standard ascorbic acid is adequate; buffered forms (calcium ascorbate, sodium ascorbate) are gentler on the stomach at higher doses.
- Liposomal vitamin C for higher bioavailability: 250-500mg liposomal vitamin C provides plasma levels equivalent to substantially higher doses of standard vitamin C for individuals with SVCT1 impairment. Consider using liposomal form during illness or high oxidative stress periods.
- Food sources with every meal: Bell peppers (190mg/100g), kiwi (93mg/100g), strawberries (59mg/100g), broccoli (89mg/100g), citrus (50-70mg per fruit). Combining supplementation with high-vitamin C foods provides matrix factors that may enhance absorption.
- Take with iron-rich meals: Vitamin C doubles non-heme iron absorption. For anyone with iron insufficiency or on a plant-based diet, pairing vitamin C supplementation with iron-containing foods (legumes, leafy greens, fortified cereals) provides dual benefit.
- Increase dramatically during illness or high oxidative stress: Immune cells deplete vitamin C rapidly during active infection. Short-term dosing of 1,000-2,000mg/day during illness is standard practice; for SVCT1 impaired individuals who start with lower baseline plasma levels, this is more important than for average absorbers.
Know your SLC23A1 genotype and understand your vitamin C absorption capacity.
Analyze Your Genome →References
Timpson NJ et al. (2010)
Genetic variation at the SLC23A1 and SLC23A2 loci is associated with plasma vitamin C concentrations. American Journal of Clinical Nutrition. GWAS of vitamin C levels and SLC23A1.
Carr AC, Frei B (1999)
Toward a new recommended dietary allowance for vitamin C based on antioxidant and health effects in humans. American Journal of Clinical Nutrition. Optimal vitamin C dose-response.
Padayatty SJ, Levine M (2016)
Vitamin C: the known and the unknown and Goldilocks. Oral Diseases. Comprehensive vitamin C biology review including transporter kinetics.
Maggini S et al. (2007)
Selected vitamins and trace elements support immune function by strengthening epithelial barriers and cellular and humoral immune responses. British Journal of Nutrition. Vitamin C and immune function.